☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Usona Institute's Psilocybin Receives the US FDA Breakthrough Therapy Designation for Major Depressive Disorder
November 22, 2019
Knight Therapeutics Signs an Exclusive License Agreement with Onconova for Rigosertib in Canada
November 22, 2019
AstraZeneca's Calquence (acalabrutinib) Receives the US FDA's Approval for Chronic Lymphocytic Leukemia Under the Project Orbis
November 22, 2019
GSK and ViiV Healthcare Sign an Exclusive License Agreement with NIH for its Investigational bNAb to Treat and Prevent HIV
November 22, 2019
Medtronic's IN.PACT AV Drug-Coated Balloon Receives the US FDA's Approval for the Treatment of Arteriovenous Fistula Lesions
November 22, 2019
BioMarin Reports Submission of MAA to EMA for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
November 22, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions